Annemieke de Jong

Annemieke de Jong

Auto-generated profile, based on publicly available information

Annemieke de Jong

Department of Dermatology, Columbia University, New York, New York, USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2014 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
LXLuzhou Xing
Luzhou Xing
ZDZhenpeng Dai
Zhenpeng Dai
AJAli Jabbari
Ali Jabbari
JCJane E Cerise
Jane E Cerise
CHClaire A Higgins
Claire A Higgins
RCRaphael Clynes
Raphael Clynes

22 January 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
RBRegina C. Betz
Regina C. Betz
LPLynn Petukhova
Lynn Petukhova
SRStephan Ripke
Stephan Ripke
HHHailiang Huang
Hailiang Huang
AMAndroniki Menelaou
Androniki Menelaou
ACAngela M. Christiano
Angela M. Christiano
Alopecia areata (AA) is a prevalent autoimmune disease with 10 known susceptibility loci. Here we perform the first meta-analysis of research on AA by combining data from two genome-wide association studies (GWAS), and replication with supplemented ImmunoChip data for a total of 3,253 cases and 7,543 controls. The strongest region of association is the major histocompatibility complex, where we fine-map four independent effects, all implicating human leukocyte antigen-DR as a key aetiologic driver. Outside the major histocompatibility complex, we identify two novel loci that exceed the threshold of statistical significance, containing ACOXL/BCL2L11(BIM) (2q13); GARP (LRRC32) (11q13.5), as well as a third nominally significant region SH2B3(LNK)/ATXN2 (12q24.12). Candidate susceptibility gene expression analysis in these regions demonstrates expression in relevant immune cells and the hair follicle. We integrate our results with data from seven other autoimmune diseases and provide insight into the alignment of AA within these disorders. Our findings uncover new molecular pathways disrupted in AA, including autophagy/apoptosis, transforming growth factor beta/Tregs and JAK kinase signalling, and support the causal role of aberrant immune processes in AA.

31 October 2010 in Nature Immunology
Verified
Journal Article
Open access
PDF file
AJAnnemieke de Jong
Annemieke de Jong
VPVictor Peña-Cruz
Victor Peña-Cruz
TCTan-Yun Cheng
Tan-Yun Cheng
RCRachael A Clark
Rachael A Clark
IRIldiko Van Rhijn
Ildiko Van Rhijn
DMD Branch Moody
D Branch Moody
The functions of the human T cell repertoires that recognize different CD1 molecules remain unknown. Moody and co-workers show that many CD1a-autoreactive T cells home to skin, where they produce IL-22. CD1 activates T cells, but the function and size of the possible human T cell repertoires that recognize each of the CD1 antigen-presenting molecules remain unknown. Using an experimental system that bypasses major histocompatibility complex (MHC) restriction and the requirement for defined antigens, we show that polyclonal T cells responded at higher rates to cells expressing CD1a than to those expressing CD1b, CD1c or CD1d. Unlike the repertoire of invariant natural killer T (NKT) cells, the CD1a-autoreactive repertoire contained diverse T cell antigen receptors (TCRs). Functionally, many CD1a-autoreactive T cells homed to skin, where they produced interleukin 22 (IL-22) in response to CD1a on Langerhans cells. The strong and frequent responses among genetically diverse donors define CD1a-autoreactive cells as a normal part of the human T cell repertoire and CD1a as a target of the TH22 subset of helper T cells.

1 August 2004 in Cancer Research
Verified
Journal Article
Closed access
AJAnnemieke de Jong
Annemieke de Jong
MPMariëtte I. E. van Poelgeest
Mariëtte I. E. van Poelgeest
JHJeanette M. van der Hulst
Jeanette M. van der Hulst
JDJan Wouter Drijfhout
Jan Wouter Drijfhout
GFGert Jan Fleuren
Gert Jan Fleuren
SBSjoerd H. van der Burg
Sjoerd H. van der Burg
Cervical cancer is the possible outcome of genital infection with high-risk human papillomavirus (HPV) and is preceded by a phase of persistent HPV infection during which the host immune system fails to eliminate the virus. Fortunately, the majority of genital HPV infections are cleared before the development of (pre)malignant lesions. Analysis of CD4+ T-helper (Th) immunity against the E2, E6, and E7 antigens of HPV16 in healthy women revealed strong proliferative E2- and E6-specific responses associated with prominent IFN-γ and interleukin 5 secretion. This indicates that the naturally arising virus-induced immune response displays a mixed Th1/Th2 cytokine profile. Of all HPV16+ cervical cancer patients, approximately half failed to mount a detectable immune response against the HPV16-derived peptides. The other half of the patients showed impaired HPV16-specific proliferative responses, which generally lacked both IFN-γ and interleukin 5. This indicates that the HPV16-specific CD4+ T-cell response in cervical cancer patients is either absent or severely impaired, despite a relatively good immune status of the patients, as indicated by intact responses against recall antigens. It is highly conceivable that proper CD4+ T-cell help is important for launching an effective immune attack against HPV because infection of cervical epithelia by this virus is, at least initially, not accompanied by gross disturbance of this tissue and/or strong proinflammatory stimuli. Therefore, our observations concerning the lack of functional HPV16-specific CD4+ T-cell immunity in patients with cervical cancer offer a possible explanation for the development of this disease.

2 June 2013 in Nature Immunology
Verified
Journal Article
Open access
PDF file
IRIldiko Van Rhijn
Ildiko Van Rhijn
AKAnne Kasmar
Anne Kasmar
AJAnnemieke de Jong
Annemieke de Jong
Stephanie GrasStephanie Gras
Stephanie Gras
MBMugdha Bhati
Mugdha Bhati
DMD Branch Moody
D Branch Moody
Moody and colleagues identify a subset of T cells with high affinity for complexes of CD1b and mycobacterial glycolipids, conserved TCRα use and biased TCRβ use. These 'GEM' T cells show interdonor conservation and proliferate after infection. Human T cell antigen receptors (TCRs) pair in millions of combinations to create complex and unique T cell repertoires for each person. Through the use of tetramers to analyze TCRs reactive to the antigen-presenting molecule CD1b, we detected T cells with highly stereotyped TCR α-chains present among genetically unrelated patients with tuberculosis. The germline-encoded, mycolyl lipid–reactive (GEM) TCRs had an α-chain bearing the variable (V) region TRAV1-2 rearranged to the joining (J) region TRAJ9 with few nontemplated (N)-region additions. Analysis of TCRs by high-throughput sequencing, binding and crystallography showed linkage of TCRα sequence motifs to high-affinity recognition of antigen. Thus, the CD1-reactive TCR repertoire is composed of at least two compartments: high-affinity GEM TCRs, and more-diverse TCRs with low affinity for CD1b-lipid complexes. We found high interdonor conservation of TCRs that probably resulted from selection by a nonpolymorphic antigen-presenting molecule and an immunodominant antigen.

17 July 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
Sjoerd H. van der BurgSjoerd H. van der Burg
Sjoerd H. van der Burg
SPSytse J. Piersma
Sytse J. Piersma
AJAnnemieke de Jong
Annemieke de Jong
JHJeanette M. van der Hulst
Jeanette M. van der Hulst
KKKitty M. C. Kwappenberg
Kitty M. C. Kwappenberg
RORienk Offringa
Rienk Offringa
Because of their important role in the maintenance of self-tolerance, CD4+regulatory T cells prevent autoimmune diseases but also curtail the efficacy of T cell immune responses against cancers. We now show that this suppressive action of CD4+regulatory T cells is not limited to cancers displaying tumor-associated self antigens, such as melanomas, but also extends to human papillomavirus (HPV)-positive cervical cancers that express foreign tumor antigens. HPV-specific CD4+T cells isolated from lymph node biopsies of cervical cancer patients were found to suppress proliferation and cytokine (IFN-γ, IL-2) production by responder T cells. The capacity of HPV-specific CD4+T cells to exert this suppressive effect depended on their activation by cognate HPV antigen and on close-range interactions with responder T cells. HPV-specific CD4+regulatory T cells were also retrieved from cervical cancer biopsies, suggesting that they interfere with the anti-tumor immune response at both the induction and effector levels. Our findings offer a plausible explanation for the observed failure of the tumor-specific immune response in patients with cervical carcinoma.